Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
Oral bisphosphonate-induced osteonecrosis complications in patients undergoing tooth extraction: a systematic review and literature updates.
Dioguardi M, Di Cosola M, Copelli C, Cantore S, Quarta C, Nitsch G, Sovereto D, Spirito F, Caloro GA, Cazzolla AP, Aiuto R, Cascardi E, Greco Lucchina A, Lo Muzio L, Ballini A, Mastrangelo F.
Eur Rev Med Pharmacol Sci. 2023 Jul;27(13):6359-6373. doi: 10.26355/eurrev_202307_32996.
Bone complications of cancer treatment.
Zhu N, Ni H, Guo S, Shen YQ, Chen Q.
Cancer Treat Rev. 2024 Nov;130:102828. doi: 10.1016/j.ctrv.2024.102828. Epub 2024 Sep 7.
Antiresorptive treatment-associated ONJ.
Eleutherakis-Papaiakovou E, Bamias A.
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12787. Epub 2017 Oct 24.
[Hip osteonecrosis].
Hernigou P.
Rev Prat. 2020 Apr;70(4):409-415.
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M.
Cancer Treat Rev. 2018 Sep;69:177-187. doi: 10.1016/j.ctrv.2018.06.007. Epub 2018 Jun 18.
Dysbaric disorders: aseptic bone necrosis in tunnel workers and divers.
Davidson JK.
Baillieres Clin Rheumatol. 1989 Apr;3(1):1-23. doi: 10.1016/s0950-3579(89)80033-0.
[Etiology, diagnostics and classification of lunate bone necrosis].
Lögters T, Büren C, Windolf J.
Unfallchirurg. 2018 May;121(5):373-380. doi: 10.1007/s00113-018-0495-6.
Diseases of Subchondral Bone 2.
Lerebours F, ElAttrache NS, Mandelbaum B.
Sports Med Arthrosc Rev. 2016 Jun;24(2):50-5. doi: 10.1097/JSA.0000000000000116.
Chemical and Radiation-Associated Jaw Lesions.
Omolehinwa TT, Akintoye SO.
Dent Clin North Am. 2016 Jan;60(1):265-77. doi: 10.1016/j.cden.2015.08.009.
